Skip to content

Assays and Diagnostics

Anti-hapten antibody problems

Haptens are small molecules bound to a larger carrier protein to enable antibody discovery. This often yields antibodies with poor affinity and selectivity. Here we discuss why this is…

Speeding the time-to-clinic with Optimer®

New research shows how Optimer can speed projects by up to 75% compared to standard antibodies. Speeding project timelines can be vital to the development of any life science product. Whether…

Expanding proteomic capabilities with Optimers

The genomic revolution brought simple, sensitive and rapid DNA sequencing, creating a step-change in our biological understanding. Next-generation proteomics is now promising to do the same for protein sequencing…

New methods for hapten bioanalysis

Anti-hapten antibodies are difficult and slow to generate limiting cheap and efficient bioanalysis in this field. Our proprietary methods offer standard assay formats, such as ELISA and lateral flow…